Breaking News

Lonza to Exit Pharma Softgels and Liquid-Filled Hard Capsules

NextPharma to acquire sites in France and UK specialized in lipid oral finished dosage forms.

By: Contract Pharma

Contract Pharma Staff

Lonza and NextPharma have formed an agreement for the potential sale of Lonza’s Ploermel, France and Edinburgh, UK sites, subject to relevant conditions and regulatory approvals.   The Ploermel and Edinburgh sites employ around 260 and 130 permanent staff respectively. They produce liquid-filled hard capsules, including Licaps, and softgels for high potent and hormonal products.   NextPharma offers specialized contract development and manufacturing organization (CDMO) services in oral and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters